NCT05786079 is a NA clinical trial of Footstrike modification in Tibial Stress Fracture, sponsored by University of Central Lancashire.

Who is sponsoring NCT05786079?

NCT05786079 is sponsored by University of Central Lancashire.

What drugs are being tested in NCT05786079?

Interventions in NCT05786079: Footstrike modification, Control.

What condition does NCT05786079 study?

NCT05786079 studies Tibial Stress Fracture.

Is NCT05786079 still recruiting?

NCT05786079 is currently completed. Last updated 7 August 2023.

Last reviewed 2023-08-07 · How we verify

NCT05786079

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Footstrike Transition on Tibial Stress Fracture Risk

Completed NA Last updated 7 August 2023

What this trial tests

NA trial testing Footstrike modification in Tibial Stress Fracture in 20 participants. Completed in 1 June 2019.

Timeline

1 June 2016

Primary endpoint
1 June 2019

1 June 2019

Quick facts

Lead sponsor	University of Central Lancashire
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	20
Start date	1 June 2016
Primary completion	1 June 2019
Estimated completion	1 June 2019

Drugs / interventions tested

Footstrike modification
Control

Conditions studied

Tibial Stress Fracture — all drugs for Tibial Stress Fracture →

Sponsor

University of Central Lancashire

Who can join

Adults 18 to 45, any sex, with Tibial Stress Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Biomechanical literature suggests that runners who utilize a mid or forefoot strike pattern may suffer from a reduced incidence of chronic injuries compared to a rearfoot strike. This investigation examined the effects of a 10-week footstrike transition intervention on tibial stress fracture risk in runners.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Central Lancashire trials

Trials by the same sponsor.

NCT07350473 — Effects of Vibration-Assisted Physical Activity in Type-2 Diabetes · NA · not yet recruiting
NCT07296068 — Can Acute Photobiomodulation Improve Balance and Cognition in Individuals With Ataxia: a Pilot Feasibility Placebo Rando · NA · not yet recruiting
NCT06901986 — Health Benefits of Tart Cherry in Crohn's Disease · NA · not yet recruiting
NCT07260903 — Can Photobiomodulation Improve Balance and Cognition in Individuals Over 60: a Pilot Feasibility Placebo Randomized Cont · NA · recruiting
NCT06559982 — Effects of a Brown Seaweed Tart Cherry Blend in Mild-moderate Hypertension · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05786079 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Central Lancashire
Last refreshed: 7 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05786079.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing